MedTrace Logo

Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men

NCT00354497 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2013-09-20

No results posted yet for this study

Summary

RATIONALE: Screening may help doctors find prostate cancer sooner, when it may be easier to treat. The amount of heterocyclic amines in the diet may affect prostate cancer screening results and the risk of prostate cancer.

PURPOSE: This phase II trial is studying prostate cancer screening and dietary heterocyclic amines in African American men.

Conditions

Interventions

OTHER

physiologic testing

OTHER

study of socioeconomic and demographic variables

PROCEDURE

evaluation of cancer risk factors

PROCEDURE

mutation carrier screening

PROCEDURE

study of high risk factors

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Lawrence Livermore National Laboratory at University of California

    lead OTHER

Principal Investigators

  • Kenneth T. Bogen, DrPH, MPH, MA, ScD · Lawrence Livermore National Laboratory at University of California

Study Design

Purpose
SCREENING

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00354497 on ClinicalTrials.gov